SHARESIFT
Healthcare · data ~15-min delayed
54.42 AUD -0.11%
| Price | 54.42 AUD |
| Day change | -0.11% |
| Market cap | 12.56B |
| 52-week range | 30.39 – 55.98 |
| P/E (trailing) | 40.0 |
| Dividend yield | 1.78% |
| Payout ratio | 60.75% |
| Return on equity | 5.69% |
| Debt / equity | 197% |
| Beta | 0.60 |
| Sector | Healthcare |
| Value score | 16 / 100 |
How the value score is calculated: 13 published tests, weighted to 100.
Ramsay Health Care Limited (RHC.AX) scores 16/100 on this site's value model, in the lower band: most of the valuation measures it checks sit on the richer side. It trades at 40.0 times trailing earnings and is classified in Healthcare. The dividend yield is 1.78%, paid from 61% of earnings. Return on equity is 6%, with debt at 197% of equity. On its filings it passes 2 of the nine Piotroski checks, which points to deteriorating fundamentals. Its Altman Z-Score places it in the distress zone. These are automated readings of reported figures, not a recommendation.
Piotroski F-Score 2 / 9 — nine pass/fail checks on profitability, leverage and efficiency, comparing the latest financial year with the one before.
Altman Z-Score 1.49 — Distress zone. The model was built for manufacturers and scores lenders and capital-heavy businesses low by construction, so read this alongside the balance sheet.
Updated · prices ~15-min delayed, fundamentals as last reported
Open full interactive analysis →See how it ranks: ASX stocks by value score
Value scoring · Piotroski F-Score · Altman Z · technicals · dividends — free, no sign-up.